Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Darolutamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,414Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RedHill Starts Ph 2 of Opaganib & Darolutamide in Prostate Cancer
    RedHill Starts Ph 2 of Opaganib & Darolutamide in Prostate Cancer

    04 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/redhill-announces-initiation-of-phase-2-study-of-opaganib-and-darolutamide-in-advanced-prostate-cancer-302367315.html

    PR NEWSWIRE
    04 Feb 2025
    Share Share
    Bayer’s pharma growth strategy progressing well as pipeline
    Bayer’s pharma growth strategy progressing well as pipeline

    15 Jan 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/bayers-pharma-growth-strategy-progressing-well-as-pipeline-advances-16667

    INDPHARMAPOST
    15 Jan 2025
    Share Share
    Orion’s partner Bayer in China for 3rd indication of darolutamide
    Orion’s partner Bayer in China for 3rd indication of darolutamide

    08 Jan 2025

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2025/orions-collaboration-partner-bayer-submits-application-in-china-for-third-indication-of-darolutamide/

    PRESS RELEASE
    08 Jan 2025
    Share Share
    FDA Accepts NDA in Metastatic Hormone-Sensitive Prostate Cancer
    FDA Accepts NDA in Metastatic Hormone-Sensitive Prostate Cancer

    21 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241120748644/en

    BUSINESSWIRE
    21 Nov 2024
    Share Share
    Bayer applies for third indication of Nubeqa in EU
    Bayer applies for third indication of Nubeqa in EU

    14 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-applies-third-indication-nubeqa-eu-2024-10-14/

    REUTERS
    14 Oct 2024
    Share Share
    Bayer Submits sNDA For NUBEQA In Prostate Cancer
    Bayer Submits sNDA For NUBEQA In Prostate Cancer

    26 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240926766866/en

    BUSINESSWIRE
    26 Sep 2024
    Share Share